Minerva (NERV) announced a leadership transition with the appointment of Jim O’Connor as chief business officer, effective April 21, as Geoff Race, the company’s president, has elected to leave the company. Race will continue to be involved with Minerva as a consultant. O’Connor most recently served at Axena Health.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NERV:
- Minerva screens first patient in roluperidone trial
- Why Is the VTI ETF Down Today? Daily Snapshot – 3/12/26
- Minerva price target raised to $7 from $4 at H.C. Wainwright
- Minerva Neurosciences Warns of Major Dilution Risk From Preferred Stock Conversions and Warrant Exercises
- Minerva files $200M mixed securities shelf